Cover Image
Market Research Report

Global Ursodeoxycholic Acid Drug Market Insights, Forecast to 2025

Published by QYResearch Product code 906177
Published Content info 143 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Ursodeoxycholic Acid Drug Market Insights, Forecast to 2025
Published: August 13, 2019 Content info: 143 Pages
Description

This report studies the global market size of Ursodeoxycholic Acid Drug in key regions like North America, Europe, Asia Pacific, South America and Middle East & Africa, focuses on the consumption of Ursodeoxycholic Acid Drug in these regions.

This research report categorizes the global Ursodeoxycholic Acid Drug market by top players/brands, region, type and end user. This report also studies the global Ursodeoxycholic Acid Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The global Ursodeoxycholic Acid Drug market size was increased to 972.32 million US$ from 632.24 million US$ in 2014, and it will reach 2189.43 million US$ in 2025, growing at CAGR of 12.24% between 2019 and 2025. In terms of volume. The objectives of this study are to define, segment, and project the size of the Ursodeoxycholic Acid Drug market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

1 Dr. Falk Pharma

2 Daewoong Pharmaceutical

3 Teva

4 Humanwell

5 Mitsubishi Tanabe Pharma

6 Lannett

7 Mylan

8 Bruschettini

9 Impax

10 Shanghai Pharma

11 Grindeks

Ursodeoxycholic Acid Drug market size by type:

1 Capsule

2 Tablet

Ursodeoxycholic Acid Drug market size by Applications:

1 Gallstone

2 Hepatopathy

3 Biliary Disease

4 Other

Ursodeoxycholic Acid Drug market size by region

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

Korea

India

Southeast Asia

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Russia

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Egypt

South Africa

Rest of Middle East & Africa

Table of Contents

1 Study Coverage 1

  • 1.1 Ursodeoxycholic Acid Drug Product Introduction 1
  • 1.2 Market Segments 1
  • 1.3 Key Manufacturers Covered 2
  • 1.4 Market by Type 3
    • 1.4.1 Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Type 3
    • 1.4.2 Capsule 5
    • 1.4.3 Tablet 5
  • 1.5 Market by Application 5
    • 1.5.1 Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Application 6
    • 1.5.2 Gallstone 7
    • 1.5.3 Hepatopathy 7
    • 1.5.4 Biliary Disease 7
  • 1.6 Study Objectives 8
  • 1.7 Years Considered 9

2 Executive Summary 10

  • 2.1 Global Ursodeoxycholic Acid Drug Market Size 10
    • 2.1.1 Global Ursodeoxycholic Acid Drug Revenue 2014-2025 10
    • 2.1.2 Global Ursodeoxycholic Acid Drug Sales 2014-2025 11
  • 2.2 Ursodeoxycholic Acid Drug Growth Rate by Region 11
    • 2.2.1 Global Ursodeoxycholic Acid Drug Sales by Region 12
    • 2.2.2 Global Ursodeoxycholic Acid Drug Revenue by Region 13

3 Breakdown Data by Manufacturer 15

  • 3.1 Ursodeoxycholic Acid Drug Sales by Manufacturer 15
    • 3.1.1 Ursodeoxycholic Acid Drug Sales by Manufacturer 15
    • 3.1.2 Ursodeoxycholic Acid Drug Sales Market Share by Manufacturer 16
  • 3.2 Ursodeoxycholic Acid Drug Revenue by Manufacturer 17
    • 3.2.1 Ursodeoxycholic Acid Drug Revenue by Manufacturer (2014-2019) 17
    • 3.2.2 Ursodeoxycholic Acid Drug Revenue Share by Manufacturer (2014-2019) 17
    • 3.2.3 Global Market Concentration Ratio (CR5) 18
  • 3.3 Ursodeoxycholic Acid Drug Price by Manufacturer 19
  • 3.4 Ursodeoxycholic Acid Drug Manufacturing Base Distribution, Product Types 19
    • 3.4.1 Ursodeoxycholic Acid Drug Manufacturers Headquarters 19
    • 3.4.2 Established Date of International Manufacturers 20
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 20

4 Breakdown Data by Type 21

  • 4.1 Global Ursodeoxycholic Acid Drug Sales by Type 21
  • 4.2 Global Ursodeoxycholic Acid Drug Revenue by Type 22
  • 4.3 Ursodeoxycholic Acid Drug Price by Type 24

5 Breakdown Data by Application 25

  • 5.1 Overview 25
  • 5.2 Global Ursodeoxycholic Acid Drug Breakdown Data by Application 25

6 North America 27

  • 6.1 North America Ursodeoxycholic Acid Drug by Country 28
    • 6.1.1 North America Ursodeoxycholic Acid Drug Sales by Country 28
    • 6.1.2 North America Ursodeoxycholic Acid Drug Revenue by Country 29
    • 6.1.3 United States 31
    • 6.1.4 Canada 32
    • 6.1.5 Mexico 33
  • 6.2 North America Ursodeoxycholic Acid Drug by Type 34
  • 6.3 North America Ursodeoxycholic Acid Drug by Application 35

7 Europe 37

  • 7.1 Europe Ursodeoxycholic Acid Drug by Country 38
    • 7.1.1 Europe Ursodeoxycholic Acid Drug Sales by Country 38
    • 7.1.2 Europe Ursodeoxycholic Acid Drug Revenue by Country 39
    • 7.1.3 Germany 41
    • 7.1.4 France 42
    • 7.1.5 UK 43
    • 7.1.6 Italy 44
    • 7.1.7 Russia 45
  • 7.2 Europe Ursodeoxycholic Acid Drug by Type 46
  • 7.3 Europe Ursodeoxycholic Acid Drug by Application 47

8 Asia Pacific 49

  • 8.1 Asia Pacific Ursodeoxycholic Acid Drug by Country 50
    • 8.1.1 Asia Pacific Ursodeoxycholic Acid Drug Sales by Country 50
    • 8.1.2 Asia Pacific Ursodeoxycholic Acid Drug Revenue by Country 51
    • 8.1.3 China 53
    • 8.1.4 Japan 54
    • 8.1.5 Korea 55
    • 8.1.6 India 56
    • 8.1.7 Southeast Asia 57
  • 8.2 Asia Pacific Ursodeoxycholic Acid Drug by Type 58
  • 8.3 Asia Pacific Ursodeoxycholic Acid Drug by Application 59

9 South America 61

  • 9.1 South America Ursodeoxycholic Acid Drug by Country 62
    • 9.1.1 South America Ursodeoxycholic Acid Drug Sales by Country 62
    • 9.1.2 South America Ursodeoxycholic Acid Drug Revenue by Country 63
    • 9.1.3 Brazil 65
    • 9.1.4 Argentina 66
  • 9.2 South America Ursodeoxycholic Acid Drug by Type 67
  • 9.3 South America Ursodeoxycholic Acid Drug by Application 68

10 Middle East and Africa 70

  • 10.1 Middle East and Africa Ursodeoxycholic Acid Drug by Country 71
    • 10.1.1 Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country 71
    • 10.1.2 Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country 72
    • 10.1.3 Egypt 74
    • 10.1.4 South Africa 75
  • 10.2 Middle East and Africa Ursodeoxycholic Acid Drug by Type 76
  • 10.3 Middle East and Africa Ursodeoxycholic Acid Drug by Application 77

11 Company Profiles 79

  • 11.1 Dr. Falk Pharma 79
    • 11.1.1 Dr. Falk Pharma Company Details 79
    • 11.1.2 Dr. Falk Pharma Business Overview 79
    • 11.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 80
    • 11.1.4 Dr. Falk Pharma Ursodeoxycholic Acid Drug Products Offered 80
    • 11.1.5 Dr. Falk Pharma Recent Development 80
  • 11.2 Daewoong Pharmaceutical 80
    • 11.2.1 Daewoong Pharmaceutical Company Details 80
    • 11.2.2 Daewoong Pharmaceutical Business Overview 81
    • 11.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 82
    • 11.2.4 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Products Offered 82
    • 11.2.5 Daewoong Pharmaceutical Recent Development 82
  • 11.3 Teva 83
    • 11.3.1 Teva Company Details 83
    • 11.3.2 Teva Business Overview 83
    • 11.3.3 Teva Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 84
    • 11.3.4 Teva Ursodeoxycholic Acid Drug Products Offered 84
    • 11.3.5 Teva Recent Development 84
  • 11.4 Humanwell Healthcare 85
    • 11.4.1 Humanwell Healthcare Company Details 85
    • 11.4.2 Humanwell Healthcare Business Overview 85
    • 11.4.3 Humanwell Healthcare Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 86
    • 11.4.4 Humanwell Healthcare Ursodeoxycholic Acid Drug Products Offered 86
    • 11.4.5 Humanwell Healthcare Recent Development 86
  • 11.5 Mitsubishi Tanabe Pharma 87
    • 11.5.1 Mitsubishi Tanabe Pharma Company Details 87
    • 11.5.2 Mitsubishi Tanabe Pharma Business Overview 87
    • 11.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 87
    • 11.5.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Products Offered 88
    • 11.5.5 Mitsubishi Tanabe Pharma Recent Development 88
  • 11.6 Lannett 88
    • 11.6.1 Lannett Company Details 88
    • 11.6.2 Lannett Business Overview 89
    • 11.6.3 Lannett Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 89
    • 11.6.4 Lannett Ursodeoxycholic Acid Drug Products Offered 90
    • 11.6.5 Lannett Recent Development 90
  • 11.7 Mylan 90
    • 11.7.1 Mylan Company Details 90
    • 11.7.2 Mylan Business Overview 91
    • 11.7.3 Mylan Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 91
    • 11.7.4 Mylan Ursodeoxycholic Acid Drug Products Offered 92
    • 11.7.5 Mylan Recent Development 92
  • 11.8 Bruschettini 92
    • 11.8.1 Bruschettini Company Details 92
    • 11.8.2 Bruschettini Business Overview 93
    • 11.8.3 Bruschettini Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 93
    • 11.8.4 Bruschettini Ursodeoxycholic Acid Drug Products Offered 94
  • 11.9 Impax 94
    • 11.9.1 Impax Company Details 94
    • 11.9.2 Impax Business Overview 95
    • 11.9.3 Impax Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 95
    • 11.9.4 Impax Ursodeoxycholic Acid Drug Products Offered 96
    • 11.9.5 Impax Recent Development 96
  • 11.10 Shanghai Pharma 96
    • 11.10.1 Shanghai Pharma Company Details 96
    • 11.10.2 Shanghai Pharma Business Overview 97
    • 11.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 97
    • 11.10.4 Shanghai Pharma Ursodeoxycholic Acid Drug Products Offered 98
    • 11.10.5 Shanghai Pharma Recent Development 98
  • 11.11 Grindeks 98
    • 11.11.1 Grindeks Company Details 98
    • 11.11.2 Grindeks Business Overview 99
    • 11.11.3 Grindeks Ursodeoxycholic Acid Drug Sales, Revenue and Gross Margin (2017-2019) 99
    • 11.11.4 Grindeks Ursodeoxycholic Acid Drug Products Offered 100
    • 11.11.5 Grindeks Recent Development 100

12 Future Forecast 101

  • 12.1 Ursodeoxycholic Acid Drug Market Forecast by Region 101
    • 12.1.1 Global Ursodeoxycholic Acid Drug Sales Forecast by Region 2020-2025 101
    • 12.1.2 Global Ursodeoxycholic Acid Drug Revenue Forecast by Region 2020-2025 102
  • 12.2 Ursodeoxycholic Acid Drug Market Forecast by Type 103
    • 12.2.1 Global Ursodeoxycholic Acid Drug Sales Forecast by Type (2020-2025) 103
    • 12.2.2 Global Ursodeoxycholic Acid Drug Revenue Forecast by Type (2020-2025) 103
  • 12.3 Ursodeoxycholic Acid Drug Market Forecast by Application 104
  • 12.4 North America Ursodeoxycholic Acid Drug Forecast 105
  • 12.5 Europe Ursodeoxycholic Acid Drug Forecast 106
  • 12.6 Asia Pacific Ursodeoxycholic Acid Drug Forecast 107
  • 12.7 South America Ursodeoxycholic Acid Drug Forecast 108
  • 12.8 Middle East and Africa Ursodeoxycholic Acid Drug Forecast 110

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 112

  • 13.1 Market Opportunities and Drivers 112
  • 13.2 Market Challenges 113
  • 13.3 Market Risks/Restraints 113
  • 13.4 Porter's Five Forces Analysis 113

14 Value Chain and Sales Channels Analysis 115

  • 14.1 Value Chain Analysis 115
  • 14.2 Ursodeoxycholic Acid Drug Customers 116
  • 14.3 Sales Channels Analysis 116
    • 14.3.1 Sales Channels 116
    • 14.3.2 Distributors 117

15 Research Findings and Conclusion 121

16 Appendix 122

  • 16.1 Research Methodology 122
    • 16.1.1 Methodology/Research Approach 122
      • 16.1.1.1 Research Programs/Design 122
      • 16.1.1.2 Market Size Estimation 123
      • 16.1.1.3 Market Breakdown and Data Triangulation 124
    • 16.1.2 Data Source 126
      • 16.1.2.1 Secondary Sources 126
      • 16.1.2.2 Primary Sources 127
  • 16.2 Author Details 128
  • 16.3 Disclaimer 128
  • Figure Ursodeoxycholic Acid Drug Product Picture 1
  • Table Ursodeoxycholic Acid Drug Market Segments 2
  • Table Key Manufacturers of Ursodeoxycholic Acid Drug Covered in 2018 3
  • Table Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Type (2019-2025) (K Units) & (Million US$) 4
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type in 2018 & 2025 4
  • Figure Capsule Product Picture 5
  • Figure Tablet Product Picture 5
  • Table Global Ursodeoxycholic Acid Drug Market Size Growth Rate by Application (2019-2025) (K Units) 6
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Application in 2018 & 2025 6
  • Figure Gallstone 7
  • Figure Hepatopathy 7
  • Figure Biliary Disease 8
  • Figure Ursodeoxycholic Acid Drug Report Years Considered 9
  • Figure Global Ursodeoxycholic Acid Drug Market Size 2014-2025 (Million US$) 10
  • Figure Global Ursodeoxycholic Acid Drug Sales 2014-2025 (K Units) 11
  • Table Global Ursodeoxycholic Acid Drug Market Size by Region 2019-2025 (K Units) & (Million US$) 11
  • Figure Global Ursodeoxycholic Acid Drug Market Size and Market Share by Regions 2019-2025 12
  • Table Global Ursodeoxycholic Acid Drug Sales by Region 2014-2019 (K Units) 12
  • Table Global Ursodeoxycholic Acid Drug Sales Market Share by Region 2014-2019 12
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Region 2014-2019 13
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Region in 2018 13
  • Table Global Ursodeoxycholic Acid Drug Revenue by Region 2014-2019 (Million US$) 13
  • Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Region 2014-2019 14
  • Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Region in 2018 14
  • Table Global Ursodeoxycholic Acid Drug Sales by Manufacturer (2017-2019) (K Units) 15
  • Table Global Ursodeoxycholic Acid Drug Sales Share by Manufacturer (2017-2019) 16
  • Figure Global Ursodeoxycholic Acid Drug Sales Share by Manufacturer in 2018 16
  • Table Ursodeoxycholic Acid Drug Revenue by Manufacturer (2017-2019) (Million USD) 17
  • Table Ursodeoxycholic Acid Drug Revenue Share by Manufacturer (2017-2019) 17
  • Figure Ursodeoxycholic Acid Drug Revenue Share by Manufacturer in 2018 18
  • Table Global Manufacturers Market Concentration Ratio (CR5) 18
  • Table Key Manufacturers Ursodeoxycholic Acid Drug Price (2017-2019) (USD/Unit) 19
  • Table Ursodeoxycholic Acid Drug Manufacturers Headquarters 19
  • Table Established Date of International Manufacturers 20
  • Table Manufacturers Mergers & Acquisitions, Expansion Plans 20
  • Table Global Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 21
  • Table Global Ursodeoxycholic Acid Drug Sales Share by Type (2014-2019) 21
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 21
  • Figure Global Ursodeoxycholic Acid Drug Sales Market Share by Type in 2018 22
  • Table Global Ursodeoxycholic Acid Drug Revenue by Type (2014-2019) (Million US$) 22
  • Table Global Ursodeoxycholic Acid Drug Revenue Share by Type (2014-2019) 22
  • Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Type (2014-2019) 23
  • Figure Global Ursodeoxycholic Acid Drug Revenue Market Share by Type in 2018 23
  • Table Ursodeoxycholic Acid Drug Price by Type (2014-2019) (USD/Unit) 24
  • Table Global Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 25
  • Table Global Ursodeoxycholic Acid Drug Sales Share by Application (2014-2019) 25
  • Figure Global Ursodeoxycholic Acid Drug Market Share by Application (2014-2019) 26
  • Figure Global Ursodeoxycholic Acid Drug Market Share by Application in 2018 26
  • Figure North America Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units) 27
  • Figure North America Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$) 27
  • Table North America Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units) 28
  • Table North America Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019) 28
  • Figure North America Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018 29
  • Table North America Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$) 29
  • Table North America Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019) 29
  • Figure North America Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018 30
  • Figure United States Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 31
  • Figure United States Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 31
  • Figure Canada Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 32
  • Figure Canada Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 32
  • Figure Mexico Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 33
  • Figure Mexico Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 33
  • Table North America Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 34
  • Table North America Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 34
  • Figure North America Ursodeoxycholic Acid Drug Market Share by Type in 2018 34
  • Table North America Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 35
  • Table North America Ursodeoxycholic Acid Drug Sales Market Share by Application (2014-2019) 35
  • Figure North America Ursodeoxycholic Acid Drug Market Share by Application in 2018 36
  • Figure Europe Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units) 37
  • Figure Europe Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$) 37
  • Table Europe Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units) 38
  • Table Europe Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019) 38
  • Figure Europe Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018 39
  • Table Europe Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$) 39
  • Table Europe Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019) 40
  • Figure Europe Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018 40
  • Figure Germany Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 41
  • Figure Germany Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 41
  • Figure France Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 42
  • Figure France Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 42
  • Figure UK Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 43
  • Figure UK Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 43
  • Figure Italy Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 44
  • Figure Italy Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 44
  • Figure Russia Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 45
  • Figure Russia Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 45
  • Table Europe Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 46
  • Table Europe Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 46
  • Figure Europe Ursodeoxycholic Acid Drug Market Share by Type in 2018 46
  • Table Europe Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 47
  • Table Europe Ursodeoxycholic Acid Drug Sales Market Share by Application (2014-2019) 47
  • Figure Europe Ursodeoxycholic Acid Drug Market Share by Application in 2018 47
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units) 49
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$) 49
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units) 50
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019) 50
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018 51
  • Table Asia Pacific Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$) 51
  • Table Asia Pacific Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019) 52
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018 52
  • Figure China Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 53
  • Figure China Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 53
  • Figure Japan Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 54
  • Figure Japan Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 54
  • Figure Korea Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 55
  • Figure Korea Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 55
  • Figure India Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 56
  • Figure India Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 56
  • Figure Southeast Asia Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 57
  • Figure Southeast Asia Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 57
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 58
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 58
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Market Share by Type in 2018 58
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 59
  • Table Asia Pacific Ursodeoxycholic Acid Drug Sales Market Share by Application (2014-2019) 59
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Market Share by Application in 2018 60
  • Figure South America Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units) 61
  • Figure South America Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$) 61
  • Table South America Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units) 62
  • Table South America Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019) 62
  • Figure South America Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018 63
  • Table South America Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$) 63
  • Table South America Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019) 63
  • Figure South America Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018 64
  • Figure Brazil Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 65
  • Figure Brazil Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 65
  • Figure Argentina Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 66
  • Figure Argentina Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 66
  • Table South America Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 67
  • Table South America Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 67
  • Figure South America Ursodeoxycholic Acid Drug Market Share by Type in 2018 67
  • Table South America Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 68
  • Table South America Ursodeoxycholic Acid Drug Sales Market Share by Application (2014-2019) 68
  • Figure South America Ursodeoxycholic Acid Drug Market Share by Application in 2018 69
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Sales Growth Rate 2014-2019 (K Units) 70
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Revenue Growth Rate 2014-2019 (Million US$) 70
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales by Country (2014-2019) (K Units) 71
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales Market Share by Country (2014-2019) 71
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Sales Market Share by Country in 2018 72
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Revenue by Country (2014-2019) (Million US$) 72
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Revenue Market Share by Country (2014-2019) 73
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Revenue Market Share by Country in 2018 73
  • Figure Egypt Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 74
  • Figure Egypt Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 74
  • Figure South Africa Ursodeoxycholic Acid Drug Sales Growth Rate (2014-2019) (K Units) 75
  • Figure South Africa Ursodeoxycholic Acid Drug Revenue Growth Rate (2014-2019) (Million US$) 75
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales by Type (2014-2019) (K Units) 76
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales Market Share by Type (2014-2019) 76
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Market Share by Type in 2018 76
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales by Application (2014-2019) (K Units) 77
  • Table Middle East and Africa Ursodeoxycholic Acid Drug Sales Market Share by Application (2014-2019) 77
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Market Share by Application in 2018 78
  • Table Dr. Falk Pharma Company Details 79
  • Table Dr. Falk Pharma Description and Business Overview 79
  • Table Dr. Falk Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 80
  • Table Dr. Falk Pharma Ursodeoxycholic Acid Drug Product 80
  • Table Dr. Falk Pharma Recent Development 80
  • Table Daewoong Pharmaceutical Company Details 80
  • Table Daewoong Pharmaceutical Description and Business Overview 81
  • Table Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 82
  • Table Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product 82
  • Table Daewoong Pharmaceutical Recent Development 82
  • Table Teva Company Details 83
  • Table Teva Description and Business Overview 83
  • Table Teva Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 84
  • Table Teva Ursodeoxycholic Acid Drug Product 84
  • Table Teva Recent Development 84
  • Table Humanwell Healthcare Company Details 85
  • Table Humanwell Healthcare Description and Business Overview 85
  • Table Humanwell Healthcare Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 86
  • Table Humanwell Healthcare Ursodeoxycholic Acid Drug Product 86
  • Table Humanwell Healthcare Recent Development 86
  • Table Mitsubishi Tanabe Pharma Company Details 87
  • Table Mitsubishi Tanabe Pharma Description and Business Overview 87
  • Table Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 87
  • Figure Ursodeoxycholic Acid Drug Product Picture of Mitsubishi Tanabe Pharma 88
  • Table Mitsubishi Tanabe Pharma Recent Development 88
  • Table Lannett Company Details 88
  • Table Lannett Description and Business Overview 89
  • Table Lannett Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 89
  • Figure Lannett Ursodeoxycholic Acid Drug Product 90
  • Table Lannett Recent Development 90
  • Table Mylan Company Details 90
  • Table Mylan Description and Business Overview 91
  • Table Mylan Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 91
  • Table Mylan Ursodeoxycholic Acid Drug Product 92
  • Table Mylan Recent Development 92
  • Table Bruschettini Company Details 92
  • Table Bruschettini Description and Business Overview 93
  • Table Bruschettini Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 93
  • Figure Bruschettini Ursodeoxycholic Acid Drug Product 94
  • Table Impax Company Details 94
  • Table Impax Description and Business Overview 95
  • Table Impax Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 95
  • Figure Impax Ursodeoxycholic Acid Drug Product 96
  • Table Impax Recent Development 96
  • Table Shanghai Pharma Company Details 96
  • Table Shanghai Pharma Description and Business Overview 97
  • Table Shanghai Pharma Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 97
  • Figure Shanghai Pharma Ursodeoxycholic Acid Drug Product 98
  • Table Shanghai Pharma Recent Development 98
  • Table Grindeks Company Details 98
  • Table Grindeks Description and Business Overview 99
  • Table Grindeks Ursodeoxycholic Acid Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2017-2019) 99
  • Figure Grindeks Ursodeoxycholic Acid Drug Product 100
  • Table Grindeks Recent Development 100
  • Table Global Ursodeoxycholic Acid Drug Sales Forecast by Region 2020-2025 (K Units) 101
  • Table Global Ursodeoxycholic Acid Drug Sales Market Share Forecast by Region 2020-2025 101
  • Table Global Ursodeoxycholic Acid Drug Revenue Forecast by Region 2020-2025 (Million US$) 102
  • Table Global Ursodeoxycholic Acid Drug Revenue Market Share Forecast by Region 2020-2025 102
  • Table Global Ursodeoxycholic Acid Drug Sales Forecast by Type (2020-2025) (K Units) 103
  • Table Global Ursodeoxycholic Acid Drug Sales Market Share Forecast by Type (2020-2025) 103
  • Table Global Ursodeoxycholic Acid Drug Revenue Forecast by Type (2020-2025) (Million US$) 103
  • Table Global Ursodeoxycholic Acid Drug Revenue Market Share Forecast by Type (2020-2025) 104
  • Table Global Ursodeoxycholic Acid Drug Sales Forecast by Application (2020-2025) (K Units) 104
  • Table Global Ursodeoxycholic Acid Drug Sales Market Share Forecast by Application (2020-2025) 104
  • Figure North America Ursodeoxycholic Acid Drug Sales Growth Rate Forecast (2020-2025) (K Units) 105
  • Figure North America Ursodeoxycholic Acid Drug Revenue Growth Rate Forecast (2020-2025) (Million US$) 106
  • Figure Europe Ursodeoxycholic Acid Drug Sales Growth Rate Forecast (2020-2025) (K Units) 106
  • Figure Europe Ursodeoxycholic Acid Drug Revenue Growth Rate Forecast (2020-2025) (Million US$) 107
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Sales Growth Rate Forecast (2020-2025) (K Units) 107
  • Figure Asia Pacific Ursodeoxycholic Acid Drug Revenue Growth Rate Forecast (2020-2025) (Million US$) 108
  • Figure South America Ursodeoxycholic Acid Drug Sales Growth Rate Forecast (2020-2025) (K Units) 108
  • Figure South America Ursodeoxycholic Acid Drug Revenue Growth Rate Forecast (2020-2025) (Million US$) 109
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Sales Growth Rate Forecast (2020-2025) (K Units) 110
  • Figure Middle East and Africa Ursodeoxycholic Acid Drug Revenue Growth Rate Forecast (2020-2025) (Million US$) 111
  • Table Key Opportunities and Drivers: Impact Analysis (2019-2025) 112
  • Table Key Challenges 113
  • Table Market Risks 113
  • Figure Porter's Five Forces Analysis 114
  • Figure Ursodeoxycholic Acid Drug Value Chain 115
  • Figure Channels of Distribution 117
  • Table Ursodeoxycholic Acid Drug Distributors List 117
  • Figure Distributors Profiles 119
  • Table Research Programs/Design for This Report 122
  • Figure Bottom-up and Top-down Approaches for This Report 124
  • Figure Data Triangulation 125
  • Figure Key Executives Interviewed 126
  • Table Key Data Information from Secondary Sources 127
  • Table Key Data Information from Primary Sources 127
Back to Top